Katja Lakota received MSc in Pharmacy in 2003 and Ph.D. in Biomedicine in 2014 at the Faculty of Pharmacy, University of Ljubljana. She is a senior scientist at the Department of Rheumatology, University Medical Centre Ljubljana, Slovenia and a co-holder of a patent in a diagnostic assay "Fluorometric immunoassay for detection of anti-dsDNA antibodies". Starting her basic and translational research into systemic autoimmune diseases, Dr. Lakota was awarded a Fulbright scholarship and spent a research year in the laboratory of Prof. John Varga, Northwestern University, Chicago, studying the role of adiponectin anti-fibrotic signaling in fibroblasts. As an awardee of the Slovenian Research Agency post-doctoral fellowship 2018, she was investigating mechanisms, leading to fibrosis development in systemic sclerosis. Currently, her research focuses on innate immune receptors and the role of inflammation in driving fibrosis and metabolic perturbations in human and murine fibroblasts and preclinical models of fibrosis. Dr. Lakota is an assistant professor at the University of Primorska, Faculty of Mathematics, Natural Sciences and Information Technologies, Slovenia, holding courses on Structures of Biological Molecules and Systems biology in human diseases in the undergraduate study program Bioinformatics. She authored 43 scientific papers.